Key result
Severe fetal left-sided obstructive lesions are linked to ~1,000 differentially expressed placental genes vs controls.
Why the study?
The etiology of severe left-sided obstructive lesions (LSOL) often remains unknown after genetic testing, and despite preclinical models implicating placental perturbations in abnormal cardiogenesis, little is known about connections between the human placenta and fetal cardiac diseases.
Are human pregnancies complicated by severe fetal left-sided obstructive heart lesions associated with distinct placental transcriptomic and cellular states compared to healthy term pregnancies?
Case-Control (n=30)
No
Are human pregnancies complicated by severe fetal left-sided obstructive heart lesions associated with distinct placental transcriptomic and cellular states compared to healthy term pregnancies?
Term placentas from fetuses with severe left-sided heart obstruction exhibit distinct transcriptomic and cellular profiles—including upregulated heart valve and endothelial development pathways and reduced trophoblast signatures—even in the absence of overt placental histopathology.
Answers are grounded in this paper and cite their sources.
Suggests placental involvement in fetal cardiac development; extends preclinical models but leaves open causality and clinical utility.
The etiology of severe left-sided obstructive lesions (LSOL) of the heart, a common form of congenital heart disease (CHD), often remains unknown even after comprehensive genetic testing. Preclinical models implicate placental perturbations in abnormal cardiogenesis; however, little is known about connections between human placenta and fetal cardiac diseases. We profiled term placentas from severe LSOL pregnancies ( n = 20) with and without placental pathologies and healthy controls ( n = 10) to test whether severe fetal LSOL is associated with distinct transcriptomic and cellular states. Bulk RNA-sequencing of archival formalin-fixed paraffin-embedded tissues identified 1,030 differentially expressed protein-coding genes (580 [up], 450 [down]). Upregulated programs involved heart-valve development, endothelial signaling, and extracellular-matrix processes; while endocrine, trophoblast and gamma-aminobutyric acid signaling processes were downregulated. Severe LSOL pregnancies with histologically normal placentas showed enrichment of lymphatic-vascular development and cyclic-nucleotide signaling. Digital deconvolution analysis inferred reduced trophoblast fractions with reciprocal increase in endothelial and immune cell types. These findings support a unique placental gene expression in abnormal cardiac development, even in the absence of overt placental histopathology. These RNA expression signatures may serve as candidate biomarkers and lay the groundwork for mechanistic studies of the heart-placenta axis and future risk stratification in pregnancies with fetuses diagnosed with severe LSOL.
No takes yet. Share an insight, caveat, or question.
León et al. (2026) conducted a case-control in Severe fetal left-sided obstructive lesions (LSOL) of the heart (n=30). Severe fetal left-sided obstructive lesions (LSOL) vs. Healthy term pregnancies without congenital heart disease was evaluated on Differentially expressed protein-coding genes in placental tissue (|fold change| >= 1.5, adjusted P < 0.05) (p=<0.05). Severe fetal left-sided obstructive lesions were associated with 1,030 differentially expressed placental protein-coding genes vs controls.
Synapse has enriched 10 related papers. Consider them for comparative context: